Comparing outcomes associated with dose manipulations of enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients.
about
Enteric-coated mycophenolate sodium containing GvHD prophylaxis reduces GvHD rate after allogeneic HSCT.Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry.Increased incidence of endoscopic erosive esophagitis in solid organ transplant recipients.Impact of Mycophenolate Mofetil Dose Reduction on Allograft Outcomes in Kidney Transplant Recipients on Tacrolimus-Based Regimens: A Systematic Review.Strategies to prevent or reduce acute and chronic kidney injury in liver transplantation.Enteric-coated mycophenolate sodium: an update.Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.Enteric-coated mycophenolate sodium given in combination with tacrolimus has a lower incidence of serious infections in Asian renal-transplant recipients compared with mycophenolate mofetil.Enteric-coated mycophenolate sodium.Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus.Cyclosporine A and tacrolimus combined with enteric-coated mycophenolate sodium influence the plasma mycophenolic acid concentration - a randomised controlled trial in Chinese live related donor kidney transplant recipients.
P2860
Q30315933-43CBEEED-8704-4BA9-8C30-3045F88940D0Q34365272-9F68A7AC-BD3D-473A-92FC-A8CCEE28D457Q36113293-6C1F3C73-384D-40DE-B074-B3A656C2E2D0Q37838123-A60A6F2C-4B55-4539-BF83-6F338085991BQ37899942-EB2E0DBC-63D8-4DC5-8C97-ACE460D2BC91Q38199765-2BCD3E34-70EB-463C-BD54-4476C6CAA484Q38208983-62427BB4-9F6D-4883-818F-DCEF3774022EQ41107370-4B6F9FB6-6A33-4E98-8ED1-14535D91B0AFQ42925114-80404107-DCE0-422C-A4EE-A878159B54EFQ43139172-23AA68C7-3801-4711-A99D-8A64884D4FF0Q53791202-270DE666-87EF-4C20-AE90-64E4B433CFD6
P2860
Comparing outcomes associated with dose manipulations of enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Comparing outcomes associated ...... n renal transplant recipients.
@ast
Comparing outcomes associated ...... n renal transplant recipients.
@en
Comparing outcomes associated ...... n renal transplant recipients.
@nl
type
label
Comparing outcomes associated ...... n renal transplant recipients.
@ast
Comparing outcomes associated ...... n renal transplant recipients.
@en
Comparing outcomes associated ...... n renal transplant recipients.
@nl
prefLabel
Comparing outcomes associated ...... n renal transplant recipients.
@ast
Comparing outcomes associated ...... n renal transplant recipients.
@en
Comparing outcomes associated ...... n renal transplant recipients.
@nl
P2093
P1433
P1476
Comparing outcomes associated ...... n renal transplant recipients.
@en
P2093
Douglas P Slakey
Erin L McCann
Flavia A Rasetto
Kathleen L Deering
Matthew Cooper
Qing Harshaw
Sander S Florman
Stephen Arcona
P304
P356
10.1097/TP.0B013E3181B0E65E
P577
2009-08-01T00:00:00Z